Score Breakdown
Offering Ability
60
Cash Runway—
Float Risk
52
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.01 below $1 exchange minimum
Market Data
Market Cap$8.06M
Shares Outstanding971.58M
Float258.13M
Cash$83.6K
Debt$1.19M
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL WARRANT
2024-03-31
xbrl
XBRL CONVERTIBLE
2021-03-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual BRGX Dilution Snapshot
BioRegenx, Inc. (BRGX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for BRGX: xbrl on 2024-03-31; xbrl on 2021-03-31.
- Score coverage note: Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.